JPS6112899B2 - - Google Patents
Info
- Publication number
- JPS6112899B2 JPS6112899B2 JP5124077A JP5124077A JPS6112899B2 JP S6112899 B2 JPS6112899 B2 JP S6112899B2 JP 5124077 A JP5124077 A JP 5124077A JP 5124077 A JP5124077 A JP 5124077A JP S6112899 B2 JPS6112899 B2 JP S6112899B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- acid
- hydroxy
- amino acid
- heated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 235000008206 alpha-amino acids Nutrition 0.000 claims description 8
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000002844 melting Methods 0.000 claims description 4
- 230000008018 melting Effects 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 description 33
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 239000002253 acid Substances 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 150000001261 hydroxy acids Chemical class 0.000 description 6
- 235000014655 lactic acid Nutrition 0.000 description 6
- 239000004310 lactic acid Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229940061720 alpha hydroxy acid Drugs 0.000 description 5
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 238000006482 condensation reaction Methods 0.000 description 5
- 230000018044 dehydration Effects 0.000 description 5
- 238000006297 dehydration reaction Methods 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000009833 condensation Methods 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- RILPIWOPNGRASR-UHFFFAOYSA-N (2R,3S)-2-Hydroxy-3-methylpentanoic acid Natural products CCC(C)C(O)C(O)=O RILPIWOPNGRASR-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- -1 N-(α-hydroxypropionyl)-alanylalanylalanine Chemical compound 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 150000001371 alpha-amino acids Chemical class 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- BXRNXXXXHLBUKK-UHFFFAOYSA-N piperazine-2,5-dione Chemical group O=C1CNC(=O)CN1 BXRNXXXXHLBUKK-UHFFFAOYSA-N 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- WOCQGWHMXPRWHW-WUCPZUCCSA-N (2s)-2-(2-hydroxypropanoylamino)propanoic acid Chemical compound CC(O)C(=O)N[C@@H](C)C(O)=O WOCQGWHMXPRWHW-WUCPZUCCSA-N 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical class O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 1
- KEPXRYFEPIOJLJ-UHFFFAOYSA-N 2-[(2-hydroxy-3-methylpentanoyl)amino]acetic acid Chemical compound CCC(C)C(O)C(=O)NCC(O)=O KEPXRYFEPIOJLJ-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- RILPIWOPNGRASR-WHFBIAKZSA-N L-Isoleucic acid Chemical compound CC[C@H](C)[C@H](O)C(O)=O RILPIWOPNGRASR-WHFBIAKZSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明はN−(α−ヒドロキシアルカノイル)−
ペプチドの製造法に関し、詳しくは、α−ヒドロ
キシカルボン酸とα−アミノ酸を前者の融点以上
の温度に加熱して反応させることを特徴とする方
法に関する。
N−(α−ヒドロキシアルカノイル)−ペプチド
は抗ウイルス作用、抗菌作用、抗カビ作用等の生
物活性や薬理活性が着目されており、農薬、防カ
ビ塗料等の分野に有用な物質であるが、その工業
的製造法に関しては未だ充分満足すべき方法は見
当らない。
本発明者らは種々検討の結果、ジケトピペラジ
ン環がα−ヒドロキシ酸存在下の熱反応で一部開
環してN−(α−ヒドロキシアルカノイル)−ジペ
プチドを生成するとの知見を得たが、この反応に
よる方法では目的物の収率が比較的低いので、更
に引続きこの方法を改良する方向で研究を重ねた
結果、本発明の方法を完成するに至つた。
即ち、本発明の方法はα−ヒドロキシカルボン
酸とα−アミノ酸を適当な比率に混合して、α−
ヒドロキシカルボン酸の融点以上の温度に加熱し
て均一相になるまで撹拌下に反応させると容易に
脱水縮合反応が起り、N−(α−ヒドロキシアル
カノイル)−ペプチドの1種ないし混合物が得ら
れ、そしてこの反応混合物は水によく溶け、イオ
ン交換樹脂等にて処理することにより簡単に未反
応のα−ヒドロキシ酸やアミノ酸と分離すること
ができるとの知見に基づくもので、前記の方法と
較べて収率よく、しかも安価且簡単に製造し得る
利点を有する。
尚、本発明の方法は一見単純なペプチド合成法
の如く見えるが、本反応を廻る以下の諸点を考え
併せれば、可成り特異的な反応であることが窺わ
れる。例えば、
(1) 本反応は原料としてα−ヒドロキシカルボン
酸を用いるが、同じヒドロキシ酸でもβ−ヒド
ロキシカルボン酸ではこの反応は起らない。即
ち、β−ヒドロキシカルボン酸とα−アミノ酸
を混合して加熱しても脱水縮合反応が進まず、
アミノ酸がなかなか溶解しない。むりに反応を
進めようとして更に高温度にし、且長時間加熱
すると、所期の目的物とは全く異なる製造不明
の物質が生成してしまう。
(2) α−ヒドロキシカルボン酸は加熱により容易
にそれ自身環化して、グリコリド誘導体になる
ことが知られており、同様にα−アミノ酸も加
熱によりジケトピペラジン誘導体になり易いと
言われている。しかるに、α−ヒドロキシカル
ボン酸とα−アミノ酸を共存させて加熱する
と、このような環化反応が抑えられて表記の如
き鎖状の縮合物が得られる。
(3) ヒドロキシ酸とアミノ酸が分子間で脱水縮合
反応を起す場合、反応(結合)の可能性として
は2つあり、いずれが、優先するかは必ずしも
定かではない。即ち、ヒドロキシ酸とアミノ酸
の間の反応としてはa)ヒドロキシ酸のヒドロ
キシル基とアミノ酸のカルボキシル基との間の
脱水縮合によるエステル結合の生成とb)ヒド
ロキシ酸のカルボキシル基とアミノ酸のアミノ
基との間の脱水縮合によるアミド結合の生成の
2通りの可能性があるにも関らず、本発明の方
法に於いてはa)の反応は殆んど起らずに専ら
b)の反応が主反応となる。更に、ヒドロキシ
酸同志の縮合や、アミノ酸同志の縮合も抑えら
れる。尚、第1段階の縮合反応で生成したN−
(α−ヒドロキシアルカノイル)−アミノ酸の未
端カルボキシル基には、引続き次のアミノ酸が
縮合し易くなる傾向が生じる。
かくの如く、本反応はa)α−ヒドロキシ酸に
特有の反応であること、b)同一分子間の縮合、
環化反応は起り難く、専ら異分子間の反応が進む
こと、c)縮合反応に方向性、選択性があること
等の特徴を有し、それ自体さまざまな生物活性、
薬理活性を有する各種ペプチドの合成、或いはよ
り分子量の大きなポリペプチド、抗生物質等の合
成のための前駆物質の製造法として巾広く適用さ
れる。
以下、本発明の方法について更に詳細に説明す
れば、原料として用いられるα−ヒドロキシカル
ボン酸としては一般式HO−CHR1−COOH(式
中R1は水素原子又は炭素数1〜25を有する直鎖
状若しくは側鎖を有するアルキル基を表わす。)
にて表わされ、具体的には例えば、グリコール
酸、乳酸、α−オキシ酪酸、α−オキシ吉草酸、
α−オキシカプロン酸、α−オキシパルミチン
酸、α−オキシドコサン酸、α−オキシヘキサコ
サン酸、α−オキシブタン酸、α−オキシメチル
ペンタン酸、α−オキシメチルヘキサン酸等が代
表的なものとして挙げられる。また、α−アミノ
酸は一般式H2N−CHR2−COOH(式中R2は水素
原子又はアルキル基、アルケニル基、シクロアル
キル基、酸素、硫黄、或いは窒素原子等の異種原
子を含むアルキル基、アルケニル基、若しくはシ
クロアルキル基、アリル基、アラルキル基等のア
ミノ酸残基を表わす。)にて表わされ、具体的に
は例えば、グリシン、アラニン、バリン、ロイシ
ン、イソロイシン、セリン、スレオニン、リジ
ン、アルギニン、システイン、メチオニン、フエ
ニルアラニン、チロシン、プロリン、ヒドロキシ
プロリン、ヒスチジン、トリプトフアン、サルコ
シン、α−メチルアラニン、オルニチン、ホモセ
リン、ドーパ等が代表的なものとして挙げられ
る。
これらα−ヒドロキシカルボン酸とα−アミノ
酸の使用割合は通常、モル比1/1の化学量論量
で行われるが、必要に応じて、いずれか1方の成
分を若干過剰に用いることは別段差支えはない。
反応はα−ヒドロキシ酸の融点以上、好ましくは
100℃以上、180℃以下、に10分乃至数時間加熱す
ることにより行われ、この際、反応液を充分撹拌
し、また不活性ガス雰囲気中にて反応を行うこと
が好ましい。反応の進行に伴い固形分は次第に溶
解して反応終了時には均一な液体となる。反応生
成物は水に良く溶け、イオン交換樹脂、その他の
分離、精製手段により容易に未反応の原料等を分
離することができる。
以下、本発明の方法について代表的な例を示し
更に具体的に説明するが、これらの例は単なる例
示であつて本発明の方法はこれらのみに限定され
ないことは言うまでもなく、前記本発明の範囲内
にて種々実施し得ることは勿論である。尚、実施
例中“%”は“重量%”を意味する。
実施例 1
乳酸9.0g(0.1モル)とバリン18.9g(0.1モ
ル)を混合して窒素置換したガラス反応管中に封
じ、160℃の油浴中にて30分間加熱、反応させる
と反応液は均一な液体となつた。反応物を水に溶
かして高速液体クロマトグラフイーにて分析した
ところ、乳酸の転化率は62.5%であり、N−(α
−ヒドロキシプロピオニル)バリンの選択率は80
%であつた。
実施例 2
乳酸9.0gとアラニン8.9g(0.1モル)を混合し
て窒素置換したガラス反応管中に封じ、150℃の
油浴中にて30分間加熱、反応させると反応液は均
一な液体となつた。反応物を水に溶かして高速液
体クロマトグラフイーにて分析したところ乳酸の
転化率は73%であり、N−(α−ヒドロキシプロ
ピオニル)−アラニンの選択率は49%であつた。
他にN−α−ヒドロキシプロピオニル)−アラニ
ルアラニン、N−(α−ヒドロキシプロピオニ
ル)−アラニルアラニルアラニンが夫々31%、
20.5%の選択率で生成した。
比較例
β−ヒドロキシn−酪酸10g(0.1モル)とア
ラニン8.9gを混合して実施例1と全く同様の反
応を行つたが、反応は遅々として進まず、そこで
加熱開始1.0時間後に油浴の温度を180℃に上昇さ
せて引続き1時間反応させたところ、漸く均一相
の反応液が得られた。反応混合物を水に溶かして
高速液体クロマトグラフイーにて分析したがヒド
ロキシアルカノイルペプチドは全く得られず、構
造不明の物質の生成が確認されたのみであつた。
実施例 3
2−ヒドロキシ−3−メチル−ペンタン酸13.2
g(0.1モル)とグリシン7.5g(0.1モル)を混合
して窒素置換したガラス反応管中に封じ、140℃
の油浴中にて30分間加熱、反応させると反応液は
均一な液体となつた。反応物を水に溶かして高速
液体クロマトグラフイーにて分析したところ2−
ヒドロキシ−3−メチル−ペンタン酸の転化率は
35%であり、N−(2−ヒドロキシ−3−メチル
−ペンタノイル)−グリシンの選択率は56%であ
つた。他にN−(2−ヒドロキシ−3−メチルペ
ンタノイル)−グリシルグリシン、N−(2−ヒド
ロキシ−3−メチルペンタノイル)−ジグリシル
グリシンが夫々26.7%、17.3%の選択率で生成し
た。
実施例 4〜8
以下、同様にして種々のα−ヒドロキシ酸とア
ミノ酸を反応させて次のような結果を得た。
【表】DETAILED DESCRIPTION OF THE INVENTION The present invention provides N-(α-hydroxyalkanoyl)-
The present invention relates to a method for producing a peptide, and specifically relates to a method characterized by reacting an α-hydroxycarboxylic acid and an α-amino acid by heating them to a temperature equal to or higher than the melting point of the former. N-(α-hydroxyalkanoyl)-peptides are attracting attention for their biological and pharmacological activities such as antiviral, antibacterial, and antifungal effects, and are useful substances in fields such as agricultural chemicals and antifungal paints. As for its industrial production method, no fully satisfactory method has yet been found. As a result of various studies, the present inventors found that the diketopiperazine ring partially opens in a thermal reaction in the presence of an α-hydroxy acid to generate an N-(α-hydroxyalkanoyl)-dipeptide. Since the yield of the target product is relatively low in this reaction method, we continued to conduct research to improve this method, and as a result, we completed the method of the present invention. That is, the method of the present invention mixes α-hydroxycarboxylic acid and α-amino acid in an appropriate ratio to produce α-
When heated to a temperature above the melting point of the hydroxycarboxylic acid and reacted with stirring until a homogeneous phase is formed, a dehydration condensation reaction easily occurs, yielding one or a mixture of N-(α-hydroxyalkanoyl)-peptides, This is based on the knowledge that this reaction mixture is highly soluble in water and can be easily separated from unreacted α-hydroxy acids and amino acids by treatment with an ion exchange resin. It has the advantage of being easy to produce, with high yield, and at low cost. At first glance, the method of the present invention appears to be a simple peptide synthesis method, but if we consider the following points surrounding this reaction, it appears to be a fairly specific reaction. For example, (1) This reaction uses α-hydroxycarboxylic acid as a raw material, but this reaction does not occur with β-hydroxycarboxylic acid, even if the same hydroxy acid is used. That is, even if β-hydroxycarboxylic acid and α-amino acid are mixed and heated, the dehydration condensation reaction does not proceed.
Amino acids are difficult to dissolve. If the reaction is forced to proceed at a higher temperature and heated for a longer period of time, an unknown substance that is completely different from the intended target product will be produced. (2) α-Hydroxycarboxylic acids are known to easily cyclize themselves into glycolide derivatives when heated, and α-amino acids are said to similarly easily become diketopiperazine derivatives when heated. . However, when an α-hydroxycarboxylic acid and an α-amino acid are coexisting and heated, such a cyclization reaction is suppressed and a chain-like condensate as shown is obtained. (3) When a hydroxy acid and an amino acid undergo a dehydration condensation reaction between molecules, there are two possibilities for the reaction (bonding), and it is not necessarily certain which one takes priority. That is, the reaction between a hydroxy acid and an amino acid involves a) formation of an ester bond through dehydration condensation between the hydroxyl group of the hydroxy acid and the carboxyl group of the amino acid, and b) formation of an ester bond between the carboxyl group of the hydroxy acid and the amino group of the amino acid. Although there are two possibilities of forming an amide bond through dehydration condensation between It becomes a reaction. Furthermore, condensation between hydroxy acids and amino acids can be suppressed. Note that the N- produced in the first stage condensation reaction
The terminal carboxyl group of the (α-hydroxyalkanoyl)-amino acid tends to be easily condensed with the next amino acid. As described above, this reaction is a) a reaction specific to α-hydroxy acids, b) condensation between the same molecules,
The cyclization reaction is difficult to occur, and the reaction proceeds exclusively between different molecules, and c) the condensation reaction has directionality and selectivity.
It is widely applied as a method for producing precursors for the synthesis of various peptides with pharmacological activity, or for the synthesis of polypeptides with larger molecular weights, antibiotics, etc. To explain the method of the present invention in more detail below, the α-hydroxycarboxylic acid used as a raw material has the general formula HO-CHR 1 -COOH (wherein R 1 is a hydrogen atom or a straight carbon number having 1 to 25 carbon atoms). (Represents an alkyl group having a chain or side chain.)
Specifically, for example, glycolic acid, lactic acid, α-oxybutyric acid, α-oxyvaleric acid,
Typical examples include α-oxycaproic acid, α-oxypalmitic acid, α-oxydocosanoic acid, α-oxyhexacosanoic acid, α-oxybutanoic acid, α-oxymethylpentanoic acid, α-oxymethylhexanoic acid, etc. Can be mentioned. In addition, α-amino acids have the general formula H 2 N-CHR 2 -COOH (where R 2 is a hydrogen atom or an alkyl group containing a heteroatom such as an alkyl group, an alkenyl group, a cycloalkyl group, an oxygen, sulfur, or a nitrogen atom). , an alkenyl group, or an amino acid residue such as a cycloalkyl group, allyl group, or aralkyl group), specifically, for example, glycine, alanine, valine, leucine, isoleucine, serine, threonine, lysine. , arginine, cysteine, methionine, phenylalanine, tyrosine, proline, hydroxyproline, histidine, tryptophan, sarcosine, α-methylalanine, ornithine, homoserine, and dopa. The ratio of α-hydroxycarboxylic acid and α-amino acid used is usually a stoichiometric amount with a molar ratio of 1/1, but if necessary, it is possible to use a slight excess of either component. There is no problem.
The reaction is carried out at a temperature above the melting point of the α-hydroxy acid, preferably
The reaction is carried out by heating at 100° C. or higher and 180° C. or lower for 10 minutes to several hours. At this time, it is preferable to sufficiently stir the reaction solution and conduct the reaction in an inert gas atmosphere. As the reaction progresses, the solid content gradually dissolves and becomes a homogeneous liquid at the end of the reaction. The reaction product is highly soluble in water, and unreacted raw materials can be easily separated using an ion exchange resin or other separation and purification means. Hereinafter, representative examples of the method of the present invention will be shown and explained in more detail. However, it goes without saying that these examples are merely illustrative and the method of the present invention is not limited to these. Of course, various implementations can be made within the scope. In the examples, "%" means "% by weight". Example 1 9.0 g (0.1 mol) of lactic acid and 18.9 g (0.1 mol) of valine were mixed, sealed in a glass reaction tube purged with nitrogen, heated in an oil bath at 160°C for 30 minutes, and allowed to react. It became a homogeneous liquid. When the reaction product was dissolved in water and analyzed by high performance liquid chromatography, the conversion rate of lactic acid was 62.5%, and the conversion rate of lactic acid was 62.5%.
-Hydroxypropionyl)valine selectivity is 80
It was %. Example 2 9.0 g of lactic acid and 8.9 g (0.1 mol) of alanine were mixed, sealed in a glass reaction tube purged with nitrogen, heated in a 150°C oil bath for 30 minutes, and allowed to react. The reaction solution became a homogeneous liquid. Summer. When the reactant was dissolved in water and analyzed by high performance liquid chromatography, the conversion rate of lactic acid was 73% and the selectivity of N-(α-hydroxypropionyl)-alanine was 49%.
In addition, 31% each of N-α-hydroxypropionyl)-alanylalanine and N-(α-hydroxypropionyl)-alanylalanylalanine,
It was produced with a selectivity of 20.5%. Comparative Example 10 g (0.1 mol) of β-hydroxy n-butyric acid and 8.9 g of alanine were mixed and a reaction was carried out in exactly the same manner as in Example 1. However, the reaction did not proceed slowly, and 1.0 hours after the start of heating, the reaction was carried out in an oil bath. When the temperature was raised to 180°C and the reaction was continued for 1 hour, a homogeneous reaction solution was finally obtained. The reaction mixture was dissolved in water and analyzed by high performance liquid chromatography, but no hydroxyalkanoyl peptide was obtained, and only the production of a substance of unknown structure was confirmed. Example 3 2-Hydroxy-3-methyl-pentanoic acid 13.2
g (0.1 mol) and glycine 7.5 g (0.1 mol) were mixed, sealed in a glass reaction tube purged with nitrogen, and heated at 140°C.
After heating and reacting in an oil bath for 30 minutes, the reaction solution became a homogeneous liquid. When the reaction product was dissolved in water and analyzed using high performance liquid chromatography, 2-
The conversion rate of hydroxy-3-methyl-pentanoic acid is
The selectivity for N-(2-hydroxy-3-methyl-pentanoyl)-glycine was 56%. In addition, N-(2-hydroxy-3-methylpentanoyl)-glycylglycine and N-(2-hydroxy-3-methylpentanoyl)-diglycylglycine were produced with selectivities of 26.7% and 17.3%, respectively. . Examples 4 to 8 Various α-hydroxy acids and amino acids were reacted in the same manner, and the following results were obtained. 【table】
Claims (1)
前者の融点以上の温度に加熱して反応させること
を特徴とするN−(α−ヒドロキシアルカノイ
ル)−ペプチドの製造法。1. A method for producing an N-(α-hydroxyalkanoyl)-peptide, which comprises reacting an α-hydroxycarboxylic acid and an α-amino acid by heating them to a temperature equal to or higher than the melting point of the former.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5124077A JPS53137911A (en) | 1977-05-06 | 1977-05-06 | Preparation of n-(alpha-hydroxyalkanoyl)-peptides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5124077A JPS53137911A (en) | 1977-05-06 | 1977-05-06 | Preparation of n-(alpha-hydroxyalkanoyl)-peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS53137911A JPS53137911A (en) | 1978-12-01 |
| JPS6112899B2 true JPS6112899B2 (en) | 1986-04-10 |
Family
ID=12881411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5124077A Granted JPS53137911A (en) | 1977-05-06 | 1977-05-06 | Preparation of n-(alpha-hydroxyalkanoyl)-peptides |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS53137911A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9700599B2 (en) | 2012-11-13 | 2017-07-11 | Adocia | Rapid-acting insulin formulation comprising a substituted anionic compound |
| US9795678B2 (en) | 2014-05-14 | 2017-10-24 | Adocia | Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound |
| US10525133B2 (en) | 2014-05-14 | 2020-01-07 | Adocia | Aqueous composition comprising at least one protein and one solubilizing agent, preparation thereof and uses thereof |
| US10792335B2 (en) | 2015-11-16 | 2020-10-06 | Adocia | Rapid-acting insulin composition comprising a substituted citrate |
-
1977
- 1977-05-06 JP JP5124077A patent/JPS53137911A/en active Granted
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9700599B2 (en) | 2012-11-13 | 2017-07-11 | Adocia | Rapid-acting insulin formulation comprising a substituted anionic compound |
| US10583175B2 (en) | 2012-11-13 | 2020-03-10 | Adocia | Rapid-acting insulin formulation comprising a substituted anionic compound |
| US9795678B2 (en) | 2014-05-14 | 2017-10-24 | Adocia | Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound |
| US10525133B2 (en) | 2014-05-14 | 2020-01-07 | Adocia | Aqueous composition comprising at least one protein and one solubilizing agent, preparation thereof and uses thereof |
| US10792335B2 (en) | 2015-11-16 | 2020-10-06 | Adocia | Rapid-acting insulin composition comprising a substituted citrate |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS53137911A (en) | 1978-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3407203A (en) | Novel process for the preparation of diketopiperazines | |
| US3052655A (en) | Thermal polymerization of amino acid mixtures containing aspartic acid or a thermal precursor of aspartic acid | |
| Denkewalter et al. | The controlled synthesis of peptides in aqueous medium. I. The use of α-amino acid N-carboxyanhydrides | |
| SU793383A3 (en) | Method of preparing alpha-aminoacid derivatives | |
| US6479665B2 (en) | Process for the preparation of N-carboxyanhydrides | |
| Ikegami et al. | Asymmetric synthesis of α-amino acids by alkylation of a glycine amide derivative bearing chiral 2, 5-disubstituted pyrrolidine as an amine component | |
| JPS6112899B2 (en) | ||
| US6603016B2 (en) | Process for the preparation of N-carboxyanhydrides | |
| CA2073818A1 (en) | Transesterification and other conversion reactions of acid derivatives, using an amidine | |
| US11453648B2 (en) | Method for producing orotic acid derivative | |
| US3462460A (en) | Alpha-amino acid anhydrides | |
| WO2019239879A1 (en) | Method for producing amide | |
| JPS5829757A (en) | Production of optically active mandelonitrile | |
| Ghosh et al. | One pot amide/peptide synthesis via two redox reactions | |
| JP2634438B2 (en) | Asymmetric bisoxazolylpyridine derivative and method for producing the same | |
| US4943679A (en) | Process for the N-ω-trifluoroacetylation of saturated aliphatic monocarboxylic α,ω-diamino acids | |
| JPS6035356B2 (en) | Method for producing pyroglutamyl peptide | |
| JP2000219683A (en) | Decarbamoylation of compound having n-carbamoyl protecting group, new carboxylic acid anhydride and use thereof | |
| Johnson et al. | 4-(Methylsufonyl) phenyl activated ester. Susceptibility to racemization. III | |
| US4789757A (en) | N-formylation of amino carboxylic compounds with formamide | |
| Hayriyan et al. | Nickel-coordinated chiral enols and Michael addition intermediate stabilized by the Ni–C bond | |
| Belokon et al. | Asymmetric synthesis of unusual α-amino acids | |
| SU629874A3 (en) | Method of obtaining enamines or salts thereof | |
| JPH03220179A (en) | Novel cyclic dipeptide derivative and its production | |
| JP2728891B2 (en) | Method for producing amino acid ester mineral salts |